Lumos Diagnostics Holdings Limited (LDXHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -8.59 Million USD | 3.27% |
| 2023 | -8.88 Million USD | 80.57% |
| 2022 | -45.72 Million USD | -202.27% |
| 2021 | -15.12 Million USD | -63.39% |
| 2020 | -9.25 Million USD | -101.55% |
| 2019 | -4.59 Million USD | -263.33% |
| 2018 | -1.26 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -8.74 Million USD | 1.6% |
| 2024 Q1 | -3.2 Million USD | -35.13% |
| 2024 Q2 | -6.69 Million USD | -108.68% |
| 2024 Q3 | -1.08 Million USD | 83.72% |
| 2024 Q4 | -1.08 Million USD | 0.0% |
| 2023 Q4 | -2.37 Million USD | -97.17% |
| 2023 FY | -8.88 Million USD | 80.57% |
| 2023 Q3 | -1.2 Million USD | 81.98% |
| 2023 Q2 | -6.67 Million USD | -103.46% |
| 2023 Q1 | -3.28 Million USD | 90.13% |
| 2022 Q4 | -33.25 Million USD | 0.0% |
| 2022 FY | -45.72 Million USD | -202.27% |
| 2022 Q2 | -10.99 Million USD | 0.0% |
| 2021 Q4 | -11.62 Million USD | 0.0% |
| 2021 Q2 | -3.57 Million USD | 0.0% |
| 2021 FY | -15.12 Million USD | -63.39% |
| 2020 Q2 | -4.38 Million USD | 0.0% |
| 2020 Q4 | -4.96 Million USD | 0.0% |
| 2020 FY | -9.25 Million USD | -101.55% |
| 2019 FY | -4.59 Million USD | -263.33% |
| 2018 FY | -1.26 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -509.362% |
| Arrayit Corporation | -3.31 Million USD | -159.139% |
| Atlantic International Corp. | -5.62 Million USD | -52.676% |
| Biocept, Inc. | -32.08 Million USD | 73.223% |
| Bioqual, Inc. | 483.48 Thousand USD | 1877.112% |
| CardioGenics Holdings Inc | -1.91 Million USD | -348.358% |
| DermTech, Inc. | -100.88 Million USD | 91.484% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.424% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 60.212% |
| iMD Companies, Inc. | -200.63 Thousand USD | -4182.382% |
| IDenta Corp. | 14.64 Thousand USD | 58772.494% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 1171.322% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 22307.863% |
| InVitro International | 1553.00 USD | 553351.771% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -14685.242% |
| Medical Imaging Corp. | -3.02 Million USD | -184.219% |
| NovelStem International Corp. | -4.18 Million USD | -105.192% |
| Optigenex Inc. | -2.89 Million USD | -196.505% |
| PharmChem, Inc. | 845.1 Thousand USD | 1116.682% |
| Proteome Sciences plc | -2.44 Million USD | -251.699% |
| Response Genetics, Inc | -20.18 Million USD | 57.432% |
| Rennova Health, Inc. | -3.29 Million USD | -160.913% |
| RushNet, Inc. | -607.02 Thousand USD | -1315.421% |
| ScreenPro Security Inc. | -2.24 Million USD | -282.076% |
| Stella Diagnostics Inc. | -5.7 Million USD | -50.541% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 24.733% |
| Todos Medical Ltd. | -24.99 Million USD | 65.624% |